Literature DB >> 27640440

Diet-induced obesity reduces the production of influenza vaccine-induced antibodies via impaired macrophage function.

W-J Cho, D-K Lee, S-Y Lee, S-H Sohn, H-L Park, Y-W Park, H Kim, J-H Nam.   

Abstract

Obesity is a metabolic disease characterized by low-level chronic inflammation. Obese individuals are susceptible to infection by viruses, and vaccination against these pathogens is less effective than in nonobese individuals. Here, we sought to explore the immunological environment in a mouse model of obesity induced by a high-fat diet (HFD). HFD treatment increased the body weight and epididymal fat mass. The proportion of activated B cells, T cells, and macrophages was similar between mice in the HFD group and the regular-fat diet (RFD) group. The Th1 cell subpopulation in the HFD group was increased, whereas the proportion of Treg cells was reduced compared with the RFD group. Moreover, T-cell proliferation and cytokine production did not differ between the groups when cells were stimulated with anti-CD3 and anti-CD28 antibodies in vitro. In macrophages, phagocytic activity was higher in mice fed an HFD than in those fed an RFD, but expression levels of CD86 and MHC class II antigens were similar. When macrophages were cultured in vitro, the proportion of CD86-expressing macrophages was lower in those isolated from mice in the HFD group than in those isolated from the RFD group. Furthermore, lipopolysaccharide-induced interleukin 6 (IL-6) and tumor necrosis factor alpha secretions were significantly reduced in macrophages isolated from the HFD group. In addition, influenza vaccine-induced antibodies in the HFD group diminished more rapidly than in the RFD group. These results suggest that poor functionality of macrophages during obesity might contribute to a reduction in vaccine efficacy.

Entities:  

Keywords:  high-fat diet; macrophage; obesity; vaccine efficacy.

Mesh:

Substances:

Year:  2016        PMID: 27640440     DOI: 10.4149/av_2016_03_298

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  7 in total

1.  Influenza in obese travellers: increased risk and complications, decreased vaccine effectiveness.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  J Travel Med       Date:  2019-05-10       Impact factor: 8.490

2.  Immunogenicity of an AAV-Based COVID-19 Vaccine in Murine Models of Obesity and Aging.

Authors:  Dawid Maciorowski; Cheikh Diop; Urja Bhatt; Reynette Estelien; Dan Li; Ruchi Chauhan; Luk H Vandenberghe; Nerea Zabaleta
Journal:  Viruses       Date:  2022-04-15       Impact factor: 5.818

3.  How holobionts get sick-toward a unifying scheme of disease.

Authors:  Silvio D Pitlik; Omry Koren
Journal:  Microbiome       Date:  2017-06-24       Impact factor: 14.650

Review 4.  Strengthening the Immune System and Reducing Inflammation and Oxidative Stress through Diet and Nutrition: Considerations during the COVID-19 Crisis.

Authors:  Mohammed Iddir; Alex Brito; Giulia Dingeo; Sofia Sosa Fernandez Del Campo; Hanen Samouda; Michael R La Frano; Torsten Bohn
Journal:  Nutrients       Date:  2020-05-27       Impact factor: 5.717

Review 5.  Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution.

Authors:  Rebekah Honce; Stacey Schultz-Cherry
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

Review 6.  Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).

Authors:  Yue Zhou; Jingwei Chi; Wenshan Lv; Yangang Wang
Journal:  Diabetes Metab Res Rev       Date:  2020-07-20       Impact factor: 8.128

7.  High-fat diet-induced obesity affects alpha 7 nicotine acetylcholine receptor expressions in mouse lung myeloid cells.

Authors:  Yong Qi; Dan Si; Li Zhu; Yanan Qi; Zhuhua Wu; Dan Chen; Yunlei Yang
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.